nodes	percent_of_prediction	percent_of_DWPC	metapath
Hydrocodone—CYP3A4—Pimecrolimus—atopic dermatitis	0.109	0.182	CbGbCtD
Hydrocodone—CYP2D6—Loratadine—atopic dermatitis	0.0748	0.125	CbGbCtD
Hydrocodone—CYP2D6—Diphenhydramine—atopic dermatitis	0.0748	0.125	CbGbCtD
Hydrocodone—CYP3A4—Tacrolimus—atopic dermatitis	0.065	0.108	CbGbCtD
Hydrocodone—CYP3A4—Loratadine—atopic dermatitis	0.0476	0.0794	CbGbCtD
Hydrocodone—CYP3A4—Methylprednisolone—atopic dermatitis	0.0435	0.0726	CbGbCtD
Hydrocodone—CYP3A4—Triamcinolone—atopic dermatitis	0.033	0.055	CbGbCtD
Hydrocodone—CYP3A4—Betamethasone—atopic dermatitis	0.0283	0.0472	CbGbCtD
Hydrocodone—CYP3A4—Prednisolone—atopic dermatitis	0.0279	0.0466	CbGbCtD
Hydrocodone—CYP3A4—Hydrocortisone—atopic dermatitis	0.0265	0.0442	CbGbCtD
Hydrocodone—CYP3A4—Prednisone—atopic dermatitis	0.0264	0.044	CbGbCtD
Hydrocodone—CYP2D6—Dexamethasone—atopic dermatitis	0.0259	0.0432	CbGbCtD
Hydrocodone—CYP3A4—Dexamethasone—atopic dermatitis	0.0165	0.0275	CbGbCtD
Hydrocodone—Mood swings—Triamcinolone—atopic dermatitis	0.000693	0.00223	CcSEcCtD
Hydrocodone—Mood swings—Methylprednisolone—atopic dermatitis	0.000691	0.00223	CcSEcCtD
Hydrocodone—Nausea—Dimenhydrinate—atopic dermatitis	0.000691	0.00222	CcSEcCtD
Hydrocodone—Nausea—Diphenhydramine—atopic dermatitis	0.000691	0.00222	CcSEcCtD
Hydrocodone—Paraesthesia—Mometasone—atopic dermatitis	0.00069	0.00222	CcSEcCtD
Hydrocodone—Dyspnoea—Mometasone—atopic dermatitis	0.000686	0.00221	CcSEcCtD
Hydrocodone—Lethargy—Betamethasone—atopic dermatitis	0.000677	0.00218	CcSEcCtD
Hydrocodone—Lethargy—Dexamethasone—atopic dermatitis	0.000677	0.00218	CcSEcCtD
Hydrocodone—Nausea—Pimecrolimus—atopic dermatitis	0.000668	0.00215	CcSEcCtD
Hydrocodone—Osteoarthritis—Betamethasone—atopic dermatitis	0.000664	0.00214	CcSEcCtD
Hydrocodone—Osteoarthritis—Dexamethasone—atopic dermatitis	0.000664	0.00214	CcSEcCtD
Hydrocodone—Fatigue—Mometasone—atopic dermatitis	0.000663	0.00213	CcSEcCtD
Hydrocodone—Cough—Tacrolimus—atopic dermatitis	0.000654	0.00211	CcSEcCtD
Hydrocodone—Migraine—Dexamethasone—atopic dermatitis	0.000653	0.0021	CcSEcCtD
Hydrocodone—Affect lability—Dexamethasone—atopic dermatitis	0.000653	0.0021	CcSEcCtD
Hydrocodone—Affect lability—Betamethasone—atopic dermatitis	0.000653	0.0021	CcSEcCtD
Hydrocodone—Migraine—Betamethasone—atopic dermatitis	0.000653	0.0021	CcSEcCtD
Hydrocodone—Convulsion—Tacrolimus—atopic dermatitis	0.00065	0.00209	CcSEcCtD
Hydrocodone—Asthenia—Loratadine—atopic dermatitis	0.000643	0.00207	CcSEcCtD
Hydrocodone—Myalgia—Tacrolimus—atopic dermatitis	0.000638	0.00205	CcSEcCtD
Hydrocodone—Arthralgia—Tacrolimus—atopic dermatitis	0.000638	0.00205	CcSEcCtD
Hydrocodone—Body temperature increased—Fluocinolone Acetonide—atopic dermatitis	0.000637	0.00205	CcSEcCtD
Hydrocodone—Anxiety—Tacrolimus—atopic dermatitis	0.000636	0.00205	CcSEcCtD
Hydrocodone—Unspecified disorder of skin and subcutaneous tissue—Tacrolimus—atopic dermatitis	0.000634	0.00204	CcSEcCtD
Hydrocodone—Gastrointestinal pain—Mometasone—atopic dermatitis	0.000629	0.00202	CcSEcCtD
Hydrocodone—Mood swings—Dexamethasone—atopic dermatitis	0.000629	0.00202	CcSEcCtD
Hydrocodone—Mood swings—Betamethasone—atopic dermatitis	0.000629	0.00202	CcSEcCtD
Hydrocodone—Dry mouth—Tacrolimus—atopic dermatitis	0.000624	0.00201	CcSEcCtD
Hydrocodone—Upper respiratory tract infection—Hydrocortisone—atopic dermatitis	0.000624	0.00201	CcSEcCtD
Hydrocodone—Abdominal pain—Mometasone—atopic dermatitis	0.000608	0.00196	CcSEcCtD
Hydrocodone—Body temperature increased—Mometasone—atopic dermatitis	0.000608	0.00196	CcSEcCtD
Hydrocodone—Hypokalaemia—Dexamethasone—atopic dermatitis	0.000604	0.00194	CcSEcCtD
Hydrocodone—Hypokalaemia—Betamethasone—atopic dermatitis	0.000604	0.00194	CcSEcCtD
Hydrocodone—Nervous system disorder—Tacrolimus—atopic dermatitis	0.0006	0.00193	CcSEcCtD
Hydrocodone—Thrombocytopenia—Tacrolimus—atopic dermatitis	0.000599	0.00193	CcSEcCtD
Hydrocodone—Skin disorder—Tacrolimus—atopic dermatitis	0.000594	0.00191	CcSEcCtD
Hydrocodone—Hypersensitivity—Fluocinolone Acetonide—atopic dermatitis	0.000593	0.00191	CcSEcCtD
Hydrocodone—Dizziness—Loratadine—atopic dermatitis	0.000593	0.00191	CcSEcCtD
Hydrocodone—Hyperhidrosis—Tacrolimus—atopic dermatitis	0.000592	0.0019	CcSEcCtD
Hydrocodone—Lethargy—Prednisone—atopic dermatitis	0.00059	0.0019	CcSEcCtD
Hydrocodone—Upper respiratory tract infection—Triamcinolone—atopic dermatitis	0.000588	0.00189	CcSEcCtD
Hydrocodone—Osteoarthritis—Prednisone—atopic dermatitis	0.000578	0.00186	CcSEcCtD
Hydrocodone—Hypotension—Tacrolimus—atopic dermatitis	0.000572	0.00184	CcSEcCtD
Hydrocodone—Pruritus—Fluocinolone Acetonide—atopic dermatitis	0.00057	0.00183	CcSEcCtD
Hydrocodone—Vomiting—Loratadine—atopic dermatitis	0.00057	0.00183	CcSEcCtD
Hydrocodone—Affect lability—Prednisone—atopic dermatitis	0.000569	0.00183	CcSEcCtD
Hydrocodone—Rash—Loratadine—atopic dermatitis	0.000565	0.00182	CcSEcCtD
Hydrocodone—Dermatitis—Loratadine—atopic dermatitis	0.000564	0.00182	CcSEcCtD
Hydrocodone—Headache—Loratadine—atopic dermatitis	0.000561	0.00181	CcSEcCtD
Hydrocodone—Musculoskeletal discomfort—Tacrolimus—atopic dermatitis	0.000558	0.00179	CcSEcCtD
Hydrocodone—Insomnia—Tacrolimus—atopic dermatitis	0.000554	0.00178	CcSEcCtD
Hydrocodone—Asthenia—Mometasone—atopic dermatitis	0.000552	0.00178	CcSEcCtD
Hydrocodone—Paraesthesia—Tacrolimus—atopic dermatitis	0.00055	0.00177	CcSEcCtD
Hydrocodone—Mood swings—Prednisone—atopic dermatitis	0.000548	0.00176	CcSEcCtD
Hydrocodone—Dyspnoea—Tacrolimus—atopic dermatitis	0.000546	0.00176	CcSEcCtD
Hydrocodone—Somnolence—Tacrolimus—atopic dermatitis	0.000544	0.00175	CcSEcCtD
Hydrocodone—Pruritus—Mometasone—atopic dermatitis	0.000544	0.00175	CcSEcCtD
Hydrocodone—Dizziness—Fluocinolone Acetonide—atopic dermatitis	0.000533	0.00171	CcSEcCtD
Hydrocodone—Nausea—Loratadine—atopic dermatitis	0.000532	0.00171	CcSEcCtD
Hydrocodone—Gastrointestinal disorder—Tacrolimus—atopic dermatitis	0.000528	0.0017	CcSEcCtD
Hydrocodone—Connective tissue disorder—Hydrocortisone—atopic dermatitis	0.000528	0.0017	CcSEcCtD
Hydrocodone—Fatigue—Tacrolimus—atopic dermatitis	0.000528	0.0017	CcSEcCtD
Hydrocodone—Hypokalaemia—Prednisone—atopic dermatitis	0.000526	0.00169	CcSEcCtD
Hydrocodone—Constipation—Tacrolimus—atopic dermatitis	0.000523	0.00168	CcSEcCtD
Hydrocodone—Vomiting—Fluocinolone Acetonide—atopic dermatitis	0.000512	0.00165	CcSEcCtD
Hydrocodone—Rash—Fluocinolone Acetonide—atopic dermatitis	0.000508	0.00163	CcSEcCtD
Hydrocodone—Dermatitis—Fluocinolone Acetonide—atopic dermatitis	0.000507	0.00163	CcSEcCtD
Hydrocodone—Headache—Fluocinolone Acetonide—atopic dermatitis	0.000505	0.00162	CcSEcCtD
Hydrocodone—Gastrointestinal pain—Tacrolimus—atopic dermatitis	0.0005	0.00161	CcSEcCtD
Hydrocodone—Connective tissue disorder—Methylprednisolone—atopic dermatitis	0.000496	0.0016	CcSEcCtD
Hydrocodone—Vomiting—Mometasone—atopic dermatitis	0.000489	0.00157	CcSEcCtD
Hydrocodone—Rash—Mometasone—atopic dermatitis	0.000485	0.00156	CcSEcCtD
Hydrocodone—Dermatitis—Mometasone—atopic dermatitis	0.000484	0.00156	CcSEcCtD
Hydrocodone—Body temperature increased—Tacrolimus—atopic dermatitis	0.000484	0.00156	CcSEcCtD
Hydrocodone—Abdominal pain—Tacrolimus—atopic dermatitis	0.000484	0.00156	CcSEcCtD
Hydrocodone—Headache—Mometasone—atopic dermatitis	0.000482	0.00155	CcSEcCtD
Hydrocodone—Nausea—Fluocinolone Acetonide—atopic dermatitis	0.000478	0.00154	CcSEcCtD
Hydrocodone—Mental disorder—Hydrocortisone—atopic dermatitis	0.000471	0.00152	CcSEcCtD
Hydrocodone—Malnutrition—Hydrocortisone—atopic dermatitis	0.000468	0.00151	CcSEcCtD
Hydrocodone—Angiopathy—Methylprednisolone—atopic dermatitis	0.000458	0.00147	CcSEcCtD
Hydrocodone—Nausea—Mometasone—atopic dermatitis	0.000457	0.00147	CcSEcCtD
Hydrocodone—Mediastinal disorder—Methylprednisolone—atopic dermatitis	0.000455	0.00146	CcSEcCtD
Hydrocodone—Hypersensitivity—Tacrolimus—atopic dermatitis	0.000451	0.00145	CcSEcCtD
Hydrocodone—Mental disorder—Methylprednisolone—atopic dermatitis	0.000442	0.00142	CcSEcCtD
Hydrocodone—Malnutrition—Methylprednisolone—atopic dermatitis	0.00044	0.00141	CcSEcCtD
Hydrocodone—Asthenia—Tacrolimus—atopic dermatitis	0.000439	0.00141	CcSEcCtD
Hydrocodone—OPRM1—GPCR ligand binding—CCL22—atopic dermatitis	0.000437	0.00485	CbGpPWpGaD
Hydrocodone—Pruritus—Tacrolimus—atopic dermatitis	0.000433	0.00139	CcSEcCtD
Hydrocodone—OPRD1—Peptide ligand-binding receptors—CXCL10—atopic dermatitis	0.000428	0.00476	CbGpPWpGaD
Hydrocodone—Back pain—Triamcinolone—atopic dermatitis	0.000426	0.00137	CcSEcCtD
Hydrocodone—Angiopathy—Betamethasone—atopic dermatitis	0.000417	0.00134	CcSEcCtD
Hydrocodone—Angiopathy—Dexamethasone—atopic dermatitis	0.000417	0.00134	CcSEcCtD
Hydrocodone—OPRK1—GPCRs, Class A Rhodopsin-like—CCR3—atopic dermatitis	0.000416	0.00462	CbGpPWpGaD
Hydrocodone—Convulsion—Prednisolone—atopic dermatitis	0.000415	0.00134	CcSEcCtD
Hydrocodone—OPRD1—GPCRs, Class A Rhodopsin-like—CXCR3—atopic dermatitis	0.000415	0.00461	CbGpPWpGaD
Hydrocodone—OPRK1—GPCR ligand binding—CCL17—atopic dermatitis	0.000413	0.00459	CbGpPWpGaD
Hydrocodone—OPRD1—Class A/1 (Rhodopsin-like receptors)—CCR3—atopic dermatitis	0.000406	0.00452	CbGpPWpGaD
Hydrocodone—Convulsion—Hydrocortisone—atopic dermatitis	0.000405	0.0013	CcSEcCtD
Hydrocodone—Dizziness—Tacrolimus—atopic dermatitis	0.000405	0.0013	CcSEcCtD
Hydrocodone—OPRM1—Peptide ligand-binding receptors—NPS—atopic dermatitis	0.0004	0.00445	CbGpPWpGaD
Hydrocodone—OPRM1—Peptide ligand-binding receptors—TAC1—atopic dermatitis	0.0004	0.00445	CbGpPWpGaD
Hydrocodone—Myalgia—Hydrocortisone—atopic dermatitis	0.000398	0.00128	CcSEcCtD
Hydrocodone—Anxiety—Hydrocortisone—atopic dermatitis	0.000397	0.00128	CcSEcCtD
Hydrocodone—Unspecified disorder of skin and subcutaneous tissue—Hydrocortisone—atopic dermatitis	0.000396	0.00127	CcSEcCtD
Hydrocodone—Connective tissue disorder—Prednisone—atopic dermatitis	0.000393	0.00126	CcSEcCtD
Hydrocodone—OPRM1—Peptide ligand-binding receptors—CXCR3—atopic dermatitis	0.000392	0.00436	CbGpPWpGaD
Hydrocodone—OPRK1—G alpha (i) signalling events—CXCR3—atopic dermatitis	0.000392	0.00436	CbGpPWpGaD
Hydrocodone—Vomiting—Tacrolimus—atopic dermatitis	0.000389	0.00125	CcSEcCtD
Hydrocodone—OPRM1—GPCR ligand binding—CCL27—atopic dermatitis	0.000389	0.00433	CbGpPWpGaD
Hydrocodone—Rash—Tacrolimus—atopic dermatitis	0.000386	0.00124	CcSEcCtD
Hydrocodone—Dermatitis—Tacrolimus—atopic dermatitis	0.000386	0.00124	CcSEcCtD
Hydrocodone—Cough—Triamcinolone—atopic dermatitis	0.000384	0.00124	CcSEcCtD
Hydrocodone—Headache—Tacrolimus—atopic dermatitis	0.000383	0.00123	CcSEcCtD
Hydrocodone—Convulsion—Triamcinolone—atopic dermatitis	0.000382	0.00123	CcSEcCtD
Hydrocodone—Convulsion—Methylprednisolone—atopic dermatitis	0.000381	0.00123	CcSEcCtD
Hydrocodone—OPRD1—GPCR ligand binding—CCL11—atopic dermatitis	0.00038	0.00422	CbGpPWpGaD
Hydrocodone—OPRM1—TCR Signaling Pathway—NFKBIA—atopic dermatitis	0.000379	0.00422	CbGpPWpGaD
Hydrocodone—OPRM1—G alpha (i) signalling events—CCR3—atopic dermatitis	0.000379	0.00421	CbGpPWpGaD
Hydrocodone—Hyperhidrosis—Prednisolone—atopic dermatitis	0.000378	0.00122	CcSEcCtD
Hydrocodone—OPRK1—Peptide ligand-binding receptors—CXCL10—atopic dermatitis	0.000375	0.00417	CbGpPWpGaD
Hydrocodone—Myalgia—Triamcinolone—atopic dermatitis	0.000375	0.00121	CcSEcCtD
Hydrocodone—Nervous system disorder—Hydrocortisone—atopic dermatitis	0.000374	0.0012	CcSEcCtD
Hydrocodone—Myalgia—Methylprednisolone—atopic dermatitis	0.000374	0.0012	CcSEcCtD
Hydrocodone—Arthralgia—Methylprednisolone—atopic dermatitis	0.000374	0.0012	CcSEcCtD
Hydrocodone—Anxiety—Methylprednisolone—atopic dermatitis	0.000373	0.0012	CcSEcCtD
Hydrocodone—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—atopic dermatitis	0.000372	0.0012	CcSEcCtD
Hydrocodone—Skin disorder—Hydrocortisone—atopic dermatitis	0.000371	0.00119	CcSEcCtD
Hydrocodone—OPRM1—Class A/1 (Rhodopsin-like receptors)—CCL11—atopic dermatitis	0.000369	0.00411	CbGpPWpGaD
Hydrocodone—Hyperhidrosis—Hydrocortisone—atopic dermatitis	0.000369	0.00119	CcSEcCtD
Hydrocodone—OPRD1—Peptide ligand-binding receptors—CCL5—atopic dermatitis	0.000368	0.0041	CbGpPWpGaD
Hydrocodone—Dry mouth—Triamcinolone—atopic dermatitis	0.000367	0.00118	CcSEcCtD
Hydrocodone—OPRK1—GPCRs, Class A Rhodopsin-like—CXCR3—atopic dermatitis	0.000364	0.00404	CbGpPWpGaD
Hydrocodone—Nausea—Tacrolimus—atopic dermatitis	0.000364	0.00117	CcSEcCtD
Hydrocodone—Angiopathy—Prednisone—atopic dermatitis	0.000363	0.00117	CcSEcCtD
Hydrocodone—OPRD1—Class A/1 (Rhodopsin-like receptors)—NPS—atopic dermatitis	0.000362	0.00403	CbGpPWpGaD
Hydrocodone—OPRD1—Class A/1 (Rhodopsin-like receptors)—TAC1—atopic dermatitis	0.000362	0.00403	CbGpPWpGaD
Hydrocodone—OPRD1—G alpha (i) signalling events—CXCL10—atopic dermatitis	0.000361	0.00402	CbGpPWpGaD
Hydrocodone—Hypotension—Hydrocortisone—atopic dermatitis	0.000357	0.00115	CcSEcCtD
Hydrocodone—OPRK1—Class A/1 (Rhodopsin-like receptors)—CCR3—atopic dermatitis	0.000356	0.00396	CbGpPWpGaD
Hydrocodone—OPRD1—Class A/1 (Rhodopsin-like receptors)—CXCR3—atopic dermatitis	0.000355	0.00395	CbGpPWpGaD
Hydrocodone—Insomnia—Prednisolone—atopic dermatitis	0.000354	0.00114	CcSEcCtD
Hydrocodone—Nervous system disorder—Methylprednisolone—atopic dermatitis	0.000352	0.00113	CcSEcCtD
Hydrocodone—OPRM1—GPCRs, Class A Rhodopsin-like—CCR3—atopic dermatitis	0.000352	0.00391	CbGpPWpGaD
Hydrocodone—Paraesthesia—Prednisolone—atopic dermatitis	0.000351	0.00113	CcSEcCtD
Hydrocodone—Mental disorder—Prednisone—atopic dermatitis	0.00035	0.00113	CcSEcCtD
Hydrocodone—OPRM1—GPCR ligand binding—CCL17—atopic dermatitis	0.000349	0.00388	CbGpPWpGaD
Hydrocodone—Skin disorder—Methylprednisolone—atopic dermatitis	0.000348	0.00112	CcSEcCtD
Hydrocodone—Malnutrition—Prednisone—atopic dermatitis	0.000348	0.00112	CcSEcCtD
Hydrocodone—Musculoskeletal discomfort—Hydrocortisone—atopic dermatitis	0.000348	0.00112	CcSEcCtD
Hydrocodone—Hyperhidrosis—Triamcinolone—atopic dermatitis	0.000348	0.00112	CcSEcCtD
Hydrocodone—Hyperhidrosis—Methylprednisolone—atopic dermatitis	0.000347	0.00112	CcSEcCtD
Hydrocodone—Convulsion—Dexamethasone—atopic dermatitis	0.000346	0.00111	CcSEcCtD
Hydrocodone—Convulsion—Betamethasone—atopic dermatitis	0.000346	0.00111	CcSEcCtD
Hydrocodone—Insomnia—Hydrocortisone—atopic dermatitis	0.000345	0.00111	CcSEcCtD
Hydrocodone—Paraesthesia—Hydrocortisone—atopic dermatitis	0.000343	0.0011	CcSEcCtD
Hydrocodone—Myalgia—Betamethasone—atopic dermatitis	0.00034	0.0011	CcSEcCtD
Hydrocodone—Myalgia—Dexamethasone—atopic dermatitis	0.00034	0.0011	CcSEcCtD
Hydrocodone—Anxiety—Dexamethasone—atopic dermatitis	0.000339	0.00109	CcSEcCtD
Hydrocodone—Anxiety—Betamethasone—atopic dermatitis	0.000339	0.00109	CcSEcCtD
Hydrocodone—Hypotension—Methylprednisolone—atopic dermatitis	0.000335	0.00108	CcSEcCtD
Hydrocodone—OPRK1—GPCR ligand binding—CCL11—atopic dermatitis	0.000333	0.0037	CbGpPWpGaD
Hydrocodone—OPRD1—Peptide ligand-binding receptors—CCR5—atopic dermatitis	0.000332	0.00369	CbGpPWpGaD
Hydrocodone—OPRM1—G alpha (i) signalling events—CXCR3—atopic dermatitis	0.000331	0.00368	CbGpPWpGaD
Hydrocodone—Gastrointestinal disorder—Hydrocortisone—atopic dermatitis	0.00033	0.00106	CcSEcCtD
Hydrocodone—Fatigue—Hydrocortisone—atopic dermatitis	0.000329	0.00106	CcSEcCtD
Hydrocodone—Musculoskeletal discomfort—Triamcinolone—atopic dermatitis	0.000328	0.00105	CcSEcCtD
Hydrocodone—Musculoskeletal discomfort—Methylprednisolone—atopic dermatitis	0.000327	0.00105	CcSEcCtD
Hydrocodone—Insomnia—Triamcinolone—atopic dermatitis	0.000325	0.00105	CcSEcCtD
Hydrocodone—Insomnia—Methylprednisolone—atopic dermatitis	0.000324	0.00104	CcSEcCtD
Hydrocodone—OPRK1—Peptide ligand-binding receptors—CCL5—atopic dermatitis	0.000323	0.00359	CbGpPWpGaD
Hydrocodone—Paraesthesia—Triamcinolone—atopic dermatitis	0.000323	0.00104	CcSEcCtD
Hydrocodone—Paraesthesia—Methylprednisolone—atopic dermatitis	0.000322	0.00104	CcSEcCtD
Hydrocodone—Dyspnoea—Triamcinolone—atopic dermatitis	0.000321	0.00103	CcSEcCtD
Hydrocodone—Nervous system disorder—Betamethasone—atopic dermatitis	0.00032	0.00103	CcSEcCtD
Hydrocodone—Nervous system disorder—Dexamethasone—atopic dermatitis	0.00032	0.00103	CcSEcCtD
Hydrocodone—Thrombocytopenia—Betamethasone—atopic dermatitis	0.000319	0.00103	CcSEcCtD
Hydrocodone—Thrombocytopenia—Dexamethasone—atopic dermatitis	0.000319	0.00103	CcSEcCtD
Hydrocodone—OPRK1—Class A/1 (Rhodopsin-like receptors)—NPS—atopic dermatitis	0.000318	0.00353	CbGpPWpGaD
Hydrocodone—OPRK1—Class A/1 (Rhodopsin-like receptors)—TAC1—atopic dermatitis	0.000318	0.00353	CbGpPWpGaD
Hydrocodone—OPRM1—Peptide ligand-binding receptors—CXCL10—atopic dermatitis	0.000317	0.00353	CbGpPWpGaD
Hydrocodone—OPRK1—G alpha (i) signalling events—CXCL10—atopic dermatitis	0.000317	0.00352	CbGpPWpGaD
Hydrocodone—Hyperhidrosis—Dexamethasone—atopic dermatitis	0.000315	0.00101	CcSEcCtD
Hydrocodone—Hyperhidrosis—Betamethasone—atopic dermatitis	0.000315	0.00101	CcSEcCtD
Hydrocodone—Gastrointestinal pain—Hydrocortisone—atopic dermatitis	0.000312	0.001	CcSEcCtD
Hydrocodone—OPRK1—Class A/1 (Rhodopsin-like receptors)—CXCR3—atopic dermatitis	0.000311	0.00346	CbGpPWpGaD
Hydrocodone—OPRD1—G alpha (i) signalling events—CCL5—atopic dermatitis	0.000311	0.00346	CbGpPWpGaD
Hydrocodone—Fatigue—Triamcinolone—atopic dermatitis	0.00031	0.000997	CcSEcCtD
Hydrocodone—OPRD1—GPCR ligand binding—CCR3—atopic dermatitis	0.000309	0.00344	CbGpPWpGaD
Hydrocodone—Fatigue—Methylprednisolone—atopic dermatitis	0.000309	0.000995	CcSEcCtD
Hydrocodone—OPRM1—GPCRs, Class A Rhodopsin-like—CXCR3—atopic dermatitis	0.000307	0.00342	CbGpPWpGaD
Hydrocodone—Hypotension—Betamethasone—atopic dermatitis	0.000305	0.000981	CcSEcCtD
Hydrocodone—Hypotension—Dexamethasone—atopic dermatitis	0.000305	0.000981	CcSEcCtD
Hydrocodone—OPRD1—Signaling by GPCR—CCL22—atopic dermatitis	0.000302	0.00336	CbGpPWpGaD
Hydrocodone—Body temperature increased—Hydrocortisone—atopic dermatitis	0.000302	0.000971	CcSEcCtD
Hydrocodone—Abdominal pain—Hydrocortisone—atopic dermatitis	0.000302	0.000971	CcSEcCtD
Hydrocodone—Convulsion—Prednisone—atopic dermatitis	0.000302	0.000971	CcSEcCtD
Hydrocodone—OPRM1—Class A/1 (Rhodopsin-like receptors)—CCR3—atopic dermatitis	0.000301	0.00335	CbGpPWpGaD
Hydrocodone—Musculoskeletal discomfort—Dexamethasone—atopic dermatitis	0.000297	0.000956	CcSEcCtD
Hydrocodone—Musculoskeletal discomfort—Betamethasone—atopic dermatitis	0.000297	0.000956	CcSEcCtD
Hydrocodone—OPRD1—GPCR downstream signaling—CCL27—atopic dermatitis	0.000297	0.0033	CbGpPWpGaD
Hydrocodone—Arthralgia—Prednisone—atopic dermatitis	0.000296	0.000954	CcSEcCtD
Hydrocodone—Myalgia—Prednisone—atopic dermatitis	0.000296	0.000954	CcSEcCtD
Hydrocodone—Anxiety—Prednisone—atopic dermatitis	0.000295	0.00095	CcSEcCtD
Hydrocodone—Insomnia—Dexamethasone—atopic dermatitis	0.000295	0.000949	CcSEcCtD
Hydrocodone—Insomnia—Betamethasone—atopic dermatitis	0.000295	0.000949	CcSEcCtD
Hydrocodone—Unspecified disorder of skin and subcutaneous tissue—Prednisone—atopic dermatitis	0.000294	0.000947	CcSEcCtD
Hydrocodone—Gastrointestinal pain—Methylprednisolone—atopic dermatitis	0.000293	0.000944	CcSEcCtD
Hydrocodone—Paraesthesia—Betamethasone—atopic dermatitis	0.000293	0.000943	CcSEcCtD
Hydrocodone—Paraesthesia—Dexamethasone—atopic dermatitis	0.000293	0.000943	CcSEcCtD
Hydrocodone—OPRK1—Peptide ligand-binding receptors—CCR5—atopic dermatitis	0.000291	0.00324	CbGpPWpGaD
Hydrocodone—Hypersensitivity—Prednisolone—atopic dermatitis	0.000288	0.000927	CcSEcCtD
Hydrocodone—OPRD1—Class A/1 (Rhodopsin-like receptors)—CXCL10—atopic dermatitis	0.000287	0.00319	CbGpPWpGaD
Hydrocodone—Body temperature increased—Triamcinolone—atopic dermatitis	0.000284	0.000915	CcSEcCtD
Hydrocodone—Abdominal pain—Methylprednisolone—atopic dermatitis	0.000284	0.000913	CcSEcCtD
Hydrocodone—Gastrointestinal disorder—Betamethasone—atopic dermatitis	0.000282	0.000906	CcSEcCtD
Hydrocodone—Gastrointestinal disorder—Dexamethasone—atopic dermatitis	0.000282	0.000906	CcSEcCtD
Hydrocodone—OPRM1—GPCR ligand binding—CCL11—atopic dermatitis	0.000281	0.00313	CbGpPWpGaD
Hydrocodone—Hypersensitivity—Hydrocortisone—atopic dermatitis	0.000281	0.000905	CcSEcCtD
Hydrocodone—Fatigue—Dexamethasone—atopic dermatitis	0.000281	0.000905	CcSEcCtD
Hydrocodone—Fatigue—Betamethasone—atopic dermatitis	0.000281	0.000905	CcSEcCtD
Hydrocodone—OPRM1—TCR Signaling Pathway—CD4—atopic dermatitis	0.000281	0.00312	CbGpPWpGaD
Hydrocodone—OPRD1—G alpha (i) signalling events—CCR5—atopic dermatitis	0.00028	0.00311	CbGpPWpGaD
Hydrocodone—Nervous system disorder—Prednisone—atopic dermatitis	0.000279	0.000897	CcSEcCtD
Hydrocodone—Skin disorder—Prednisone—atopic dermatitis	0.000276	0.000888	CcSEcCtD
Hydrocodone—OPRD1—GPCR ligand binding—TAC1—atopic dermatitis	0.000276	0.00307	CbGpPWpGaD
Hydrocodone—OPRD1—GPCR ligand binding—NPS—atopic dermatitis	0.000276	0.00307	CbGpPWpGaD
Hydrocodone—Hyperhidrosis—Prednisone—atopic dermatitis	0.000275	0.000884	CcSEcCtD
Hydrocodone—Asthenia—Hydrocortisone—atopic dermatitis	0.000274	0.000882	CcSEcCtD
Hydrocodone—OPRM1—Peptide ligand-binding receptors—CCL5—atopic dermatitis	0.000273	0.00304	CbGpPWpGaD
Hydrocodone—OPRK1—G alpha (i) signalling events—CCL5—atopic dermatitis	0.000273	0.00303	CbGpPWpGaD
Hydrocodone—OPRK1—GPCR ligand binding—CCR3—atopic dermatitis	0.000271	0.00302	CbGpPWpGaD
Hydrocodone—OPRD1—GPCR ligand binding—CXCR3—atopic dermatitis	0.00027	0.00301	CbGpPWpGaD
Hydrocodone—Pruritus—Hydrocortisone—atopic dermatitis	0.00027	0.000869	CcSEcCtD
Hydrocodone—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARA—atopic dermatitis	0.00027	0.003	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling by GPCR—CCL27—atopic dermatitis	0.000269	0.003	CbGpPWpGaD
Hydrocodone—OPRM1—Class A/1 (Rhodopsin-like receptors)—TAC1—atopic dermatitis	0.000268	0.00298	CbGpPWpGaD
Hydrocodone—OPRM1—Class A/1 (Rhodopsin-like receptors)—NPS—atopic dermatitis	0.000268	0.00298	CbGpPWpGaD
Hydrocodone—OPRM1—G alpha (i) signalling events—CXCL10—atopic dermatitis	0.000268	0.00298	CbGpPWpGaD
Hydrocodone—Gastrointestinal pain—Betamethasone—atopic dermatitis	0.000267	0.000858	CcSEcCtD
Hydrocodone—Gastrointestinal pain—Dexamethasone—atopic dermatitis	0.000267	0.000858	CcSEcCtD
Hydrocodone—OPRK1—Signaling by GPCR—CCL22—atopic dermatitis	0.000265	0.00295	CbGpPWpGaD
Hydrocodone—Hypersensitivity—Triamcinolone—atopic dermatitis	0.000265	0.000852	CcSEcCtD
Hydrocodone—Hypersensitivity—Methylprednisolone—atopic dermatitis	0.000264	0.000851	CcSEcCtD
Hydrocodone—OPRM1—Class A/1 (Rhodopsin-like receptors)—CXCR3—atopic dermatitis	0.000263	0.00293	CbGpPWpGaD
Hydrocodone—OPRK1—GPCR downstream signaling—CCL27—atopic dermatitis	0.00026	0.00289	CbGpPWpGaD
Hydrocodone—OPRD1—GPCRs, Class A Rhodopsin-like—CCR5—atopic dermatitis	0.00026	0.00289	CbGpPWpGaD
Hydrocodone—OPRM1—TCR Signaling Pathway—IL1B—atopic dermatitis	0.000259	0.00288	CbGpPWpGaD
Hydrocodone—Musculoskeletal discomfort—Prednisone—atopic dermatitis	0.000259	0.000833	CcSEcCtD
Hydrocodone—Dizziness—Prednisolone—atopic dermatitis	0.000259	0.000832	CcSEcCtD
Hydrocodone—Asthenia—Triamcinolone—atopic dermatitis	0.000258	0.00083	CcSEcCtD
Hydrocodone—Body temperature increased—Dexamethasone—atopic dermatitis	0.000258	0.00083	CcSEcCtD
Hydrocodone—Abdominal pain—Betamethasone—atopic dermatitis	0.000258	0.00083	CcSEcCtD
Hydrocodone—Body temperature increased—Betamethasone—atopic dermatitis	0.000258	0.00083	CcSEcCtD
Hydrocodone—Abdominal pain—Dexamethasone—atopic dermatitis	0.000258	0.00083	CcSEcCtD
Hydrocodone—Asthenia—Methylprednisolone—atopic dermatitis	0.000257	0.000828	CcSEcCtD
Hydrocodone—Insomnia—Prednisone—atopic dermatitis	0.000257	0.000827	CcSEcCtD
Hydrocodone—Paraesthesia—Prednisone—atopic dermatitis	0.000255	0.000821	CcSEcCtD
Hydrocodone—Pruritus—Triamcinolone—atopic dermatitis	0.000254	0.000819	CcSEcCtD
Hydrocodone—Pruritus—Methylprednisolone—atopic dermatitis	0.000254	0.000817	CcSEcCtD
Hydrocodone—Dizziness—Hydrocortisone—atopic dermatitis	0.000252	0.000813	CcSEcCtD
Hydrocodone—OPRK1—Class A/1 (Rhodopsin-like receptors)—CXCL10—atopic dermatitis	0.000252	0.0028	CbGpPWpGaD
Hydrocodone—OPRD1—Class A/1 (Rhodopsin-like receptors)—CCL5—atopic dermatitis	0.000247	0.00275	CbGpPWpGaD
Hydrocodone—Rash—Prednisolone—atopic dermatitis	0.000246	0.000793	CcSEcCtD
Hydrocodone—Dermatitis—Prednisolone—atopic dermatitis	0.000246	0.000793	CcSEcCtD
Hydrocodone—OPRM1—Peptide ligand-binding receptors—CCR5—atopic dermatitis	0.000246	0.00274	CbGpPWpGaD
Hydrocodone—OPRK1—G alpha (i) signalling events—CCR5—atopic dermatitis	0.000246	0.00273	CbGpPWpGaD
Hydrocodone—Fatigue—Prednisone—atopic dermatitis	0.000245	0.000788	CcSEcCtD
Hydrocodone—Headache—Prednisolone—atopic dermatitis	0.000245	0.000788	CcSEcCtD
Hydrocodone—Constipation—Prednisone—atopic dermatitis	0.000243	0.000782	CcSEcCtD
Hydrocodone—Vomiting—Hydrocortisone—atopic dermatitis	0.000243	0.000781	CcSEcCtD
Hydrocodone—OPRK1—GPCR ligand binding—TAC1—atopic dermatitis	0.000242	0.00269	CbGpPWpGaD
Hydrocodone—OPRK1—GPCR ligand binding—NPS—atopic dermatitis	0.000242	0.00269	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling by GPCR—CCL17—atopic dermatitis	0.000242	0.00269	CbGpPWpGaD
Hydrocodone—Rash—Hydrocortisone—atopic dermatitis	0.000241	0.000775	CcSEcCtD
Hydrocodone—Dermatitis—Hydrocortisone—atopic dermatitis	0.000241	0.000774	CcSEcCtD
Hydrocodone—Headache—Hydrocortisone—atopic dermatitis	0.000239	0.00077	CcSEcCtD
Hydrocodone—OPRM1—TCR Signaling Pathway—MAPK8—atopic dermatitis	0.000238	0.00264	CbGpPWpGaD
Hydrocodone—Dizziness—Triamcinolone—atopic dermatitis	0.000238	0.000765	CcSEcCtD
Hydrocodone—Dizziness—Methylprednisolone—atopic dermatitis	0.000237	0.000763	CcSEcCtD
Hydrocodone—OPRK1—GPCR ligand binding—CXCR3—atopic dermatitis	0.000237	0.00264	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling by GPCR—CCL27—atopic dermatitis	0.000236	0.00263	CbGpPWpGaD
Hydrocodone—Asthenia—Betamethasone—atopic dermatitis	0.000234	0.000753	CcSEcCtD
Hydrocodone—Asthenia—Dexamethasone—atopic dermatitis	0.000234	0.000753	CcSEcCtD
Hydrocodone—Gastrointestinal pain—Prednisone—atopic dermatitis	0.000232	0.000748	CcSEcCtD
Hydrocodone—Nausea—Prednisolone—atopic dermatitis	0.000232	0.000747	CcSEcCtD
Hydrocodone—Pruritus—Betamethasone—atopic dermatitis	0.000231	0.000743	CcSEcCtD
Hydrocodone—Pruritus—Dexamethasone—atopic dermatitis	0.000231	0.000743	CcSEcCtD
Hydrocodone—OPRM1—G alpha (i) signalling events—CCL5—atopic dermatitis	0.00023	0.00256	CbGpPWpGaD
Hydrocodone—OPRM1—GPCR ligand binding—CCR3—atopic dermatitis	0.000229	0.00255	CbGpPWpGaD
Hydrocodone—Vomiting—Triamcinolone—atopic dermatitis	0.000229	0.000736	CcSEcCtD
Hydrocodone—Vomiting—Methylprednisolone—atopic dermatitis	0.000228	0.000734	CcSEcCtD
Hydrocodone—OPRK1—GPCRs, Class A Rhodopsin-like—CCR5—atopic dermatitis	0.000228	0.00253	CbGpPWpGaD
Hydrocodone—Nausea—Hydrocortisone—atopic dermatitis	0.000227	0.00073	CcSEcCtD
Hydrocodone—Rash—Triamcinolone—atopic dermatitis	0.000227	0.000729	CcSEcCtD
Hydrocodone—Dermatitis—Triamcinolone—atopic dermatitis	0.000226	0.000729	CcSEcCtD
Hydrocodone—Rash—Methylprednisolone—atopic dermatitis	0.000226	0.000728	CcSEcCtD
Hydrocodone—Dermatitis—Methylprednisolone—atopic dermatitis	0.000226	0.000727	CcSEcCtD
Hydrocodone—Headache—Triamcinolone—atopic dermatitis	0.000225	0.000725	CcSEcCtD
Hydrocodone—Headache—Methylprednisolone—atopic dermatitis	0.000225	0.000723	CcSEcCtD
Hydrocodone—Abdominal pain—Prednisone—atopic dermatitis	0.000225	0.000723	CcSEcCtD
Hydrocodone—Body temperature increased—Prednisone—atopic dermatitis	0.000225	0.000723	CcSEcCtD
Hydrocodone—OPRM1—Signaling by GPCR—CCL22—atopic dermatitis	0.000224	0.00249	CbGpPWpGaD
Hydrocodone—OPRD1—Class A/1 (Rhodopsin-like receptors)—CCR5—atopic dermatitis	0.000223	0.00248	CbGpPWpGaD
Hydrocodone—OPRM1—GPCR downstream signaling—CCL27—atopic dermatitis	0.00022	0.00245	CbGpPWpGaD
Hydrocodone—OPRD1—GPCR ligand binding—CXCL10—atopic dermatitis	0.000219	0.00243	CbGpPWpGaD
Hydrocodone—OPRK1—Class A/1 (Rhodopsin-like receptors)—CCL5—atopic dermatitis	0.000217	0.00241	CbGpPWpGaD
Hydrocodone—Dizziness—Betamethasone—atopic dermatitis	0.000216	0.000694	CcSEcCtD
Hydrocodone—Dizziness—Dexamethasone—atopic dermatitis	0.000216	0.000694	CcSEcCtD
Hydrocodone—Nausea—Triamcinolone—atopic dermatitis	0.000214	0.000687	CcSEcCtD
Hydrocodone—Nausea—Methylprednisolone—atopic dermatitis	0.000213	0.000686	CcSEcCtD
Hydrocodone—OPRM1—Class A/1 (Rhodopsin-like receptors)—CXCL10—atopic dermatitis	0.000213	0.00237	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling by GPCR—CCL17—atopic dermatitis	0.000212	0.00236	CbGpPWpGaD
Hydrocodone—Hypersensitivity—Prednisone—atopic dermatitis	0.000209	0.000674	CcSEcCtD
Hydrocodone—OPRM1—G alpha (i) signalling events—CCR5—atopic dermatitis	0.000208	0.00231	CbGpPWpGaD
Hydrocodone—Vomiting—Betamethasone—atopic dermatitis	0.000207	0.000667	CcSEcCtD
Hydrocodone—Vomiting—Dexamethasone—atopic dermatitis	0.000207	0.000667	CcSEcCtD
Hydrocodone—Rash—Betamethasone—atopic dermatitis	0.000206	0.000662	CcSEcCtD
Hydrocodone—Rash—Dexamethasone—atopic dermatitis	0.000206	0.000662	CcSEcCtD
Hydrocodone—Dermatitis—Betamethasone—atopic dermatitis	0.000205	0.000661	CcSEcCtD
Hydrocodone—Dermatitis—Dexamethasone—atopic dermatitis	0.000205	0.000661	CcSEcCtD
Hydrocodone—OPRM1—GPCR ligand binding—TAC1—atopic dermatitis	0.000204	0.00227	CbGpPWpGaD
Hydrocodone—OPRM1—GPCR ligand binding—NPS—atopic dermatitis	0.000204	0.00227	CbGpPWpGaD
Hydrocodone—Headache—Dexamethasone—atopic dermatitis	0.000204	0.000658	CcSEcCtD
Hydrocodone—Headache—Betamethasone—atopic dermatitis	0.000204	0.000658	CcSEcCtD
Hydrocodone—Asthenia—Prednisone—atopic dermatitis	0.000204	0.000656	CcSEcCtD
Hydrocodone—Pruritus—Prednisone—atopic dermatitis	0.000201	0.000647	CcSEcCtD
Hydrocodone—OPRD1—Peptide ligand-binding receptors—CXCL8—atopic dermatitis	0.000201	0.00223	CbGpPWpGaD
Hydrocodone—OPRM1—GPCR ligand binding—CXCR3—atopic dermatitis	0.0002	0.00223	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling by GPCR—CCL27—atopic dermatitis	0.0002	0.00222	CbGpPWpGaD
Hydrocodone—OPRK1—Class A/1 (Rhodopsin-like receptors)—CCR5—atopic dermatitis	0.000195	0.00217	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling by GPCR—CCL11—atopic dermatitis	0.000195	0.00217	CbGpPWpGaD
Hydrocodone—Nausea—Betamethasone—atopic dermatitis	0.000194	0.000624	CcSEcCtD
Hydrocodone—Nausea—Dexamethasone—atopic dermatitis	0.000194	0.000624	CcSEcCtD
Hydrocodone—OPRM1—GPCRs, Class A Rhodopsin-like—CCR5—atopic dermatitis	0.000193	0.00214	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—FCER2—atopic dermatitis	0.000192	0.00214	CbGpPWpGaD
Hydrocodone—OPRK1—GPCR ligand binding—CXCL10—atopic dermatitis	0.000192	0.00213	CbGpPWpGaD
Hydrocodone—OPRD1—GPCR ligand binding—CCL5—atopic dermatitis	0.000188	0.00209	CbGpPWpGaD
Hydrocodone—Dizziness—Prednisone—atopic dermatitis	0.000188	0.000605	CcSEcCtD
Hydrocodone—OPRM1—Class A/1 (Rhodopsin-like receptors)—CCL5—atopic dermatitis	0.000183	0.00204	CbGpPWpGaD
Hydrocodone—Vomiting—Prednisone—atopic dermatitis	0.000181	0.000581	CcSEcCtD
Hydrocodone—Rash—Prednisone—atopic dermatitis	0.000179	0.000576	CcSEcCtD
Hydrocodone—OPRM1—Signaling by GPCR—CCL17—atopic dermatitis	0.000179	0.00199	CbGpPWpGaD
Hydrocodone—Dermatitis—Prednisone—atopic dermatitis	0.000179	0.000576	CcSEcCtD
Hydrocodone—OPRD1—Signaling Pathways—CCL22—atopic dermatitis	0.000179	0.00199	CbGpPWpGaD
Hydrocodone—Headache—Prednisone—atopic dermatitis	0.000178	0.000573	CcSEcCtD
Hydrocodone—OPRK1—Peptide ligand-binding receptors—CXCL8—atopic dermatitis	0.000176	0.00196	CbGpPWpGaD
Hydrocodone—OPRD1—GPCR downstream signaling—CCR3—atopic dermatitis	0.000175	0.00194	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling by GPCR—CCL11—atopic dermatitis	0.000171	0.0019	CbGpPWpGaD
Hydrocodone—OPRD1—GPCR ligand binding—CCR5—atopic dermatitis	0.00017	0.00189	CbGpPWpGaD
Hydrocodone—OPRD1—G alpha (i) signalling events—CXCL8—atopic dermatitis	0.000169	0.00188	CbGpPWpGaD
Hydrocodone—Nausea—Prednisone—atopic dermatitis	0.000169	0.000543	CcSEcCtD
Hydrocodone—OPRK1—Signaling Pathways—FCER2—atopic dermatitis	0.000168	0.00187	CbGpPWpGaD
Hydrocodone—OPRK1—GPCR ligand binding—CCL5—atopic dermatitis	0.000165	0.00184	CbGpPWpGaD
Hydrocodone—OPRM1—Class A/1 (Rhodopsin-like receptors)—CCR5—atopic dermatitis	0.000165	0.00183	CbGpPWpGaD
Hydrocodone—OPRM1—GPCR ligand binding—CXCL10—atopic dermatitis	0.000162	0.0018	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—CCL27—atopic dermatitis	0.000159	0.00177	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling by GPCR—CCR3—atopic dermatitis	0.000159	0.00177	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—CCL22—atopic dermatitis	0.000157	0.00174	CbGpPWpGaD
Hydrocodone—OPRD1—GPCR downstream signaling—TAC1—atopic dermatitis	0.000156	0.00173	CbGpPWpGaD
Hydrocodone—OPRD1—GPCR downstream signaling—NPS—atopic dermatitis	0.000156	0.00173	CbGpPWpGaD
Hydrocodone—OPRK1—GPCR downstream signaling—CCR3—atopic dermatitis	0.000153	0.00171	CbGpPWpGaD
Hydrocodone—OPRD1—GPCR downstream signaling—CXCR3—atopic dermatitis	0.000153	0.0017	CbGpPWpGaD
Hydrocodone—OPRM1—TCR Signaling Pathway—IL6—atopic dermatitis	0.000152	0.00169	CbGpPWpGaD
Hydrocodone—OPRM1—Peptide ligand-binding receptors—CXCL8—atopic dermatitis	0.000149	0.00165	CbGpPWpGaD
Hydrocodone—OPRK1—GPCR ligand binding—CCR5—atopic dermatitis	0.000149	0.00165	CbGpPWpGaD
Hydrocodone—OPRK1—G alpha (i) signalling events—CXCL8—atopic dermatitis	0.000148	0.00165	CbGpPWpGaD
Hydrocodone—OPRD1—GPCR downstream signaling—IL5—atopic dermatitis	0.000145	0.00161	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling by GPCR—CCL11—atopic dermatitis	0.000144	0.00161	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—CCL17—atopic dermatitis	0.000143	0.00159	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—FCER2—atopic dermatitis	0.000142	0.00158	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling by GPCR—NPS—atopic dermatitis	0.000142	0.00157	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling by GPCR—TAC1—atopic dermatitis	0.000142	0.00157	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—CCL27—atopic dermatitis	0.00014	0.00155	CbGpPWpGaD
Hydrocodone—OPRM1—GPCR ligand binding—CCL5—atopic dermatitis	0.000139	0.00155	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling by GPCR—CCR3—atopic dermatitis	0.000139	0.00155	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling by GPCR—CXCR3—atopic dermatitis	0.000139	0.00154	CbGpPWpGaD
Hydrocodone—OPRK1—GPCR downstream signaling—TAC1—atopic dermatitis	0.000137	0.00152	CbGpPWpGaD
Hydrocodone—OPRK1—GPCR downstream signaling—NPS—atopic dermatitis	0.000137	0.00152	CbGpPWpGaD
Hydrocodone—OPRD1—Class A/1 (Rhodopsin-like receptors)—CXCL8—atopic dermatitis	0.000135	0.0015	CbGpPWpGaD
Hydrocodone—OPRK1—GPCR downstream signaling—CXCR3—atopic dermatitis	0.000134	0.00149	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—CCL22—atopic dermatitis	0.000132	0.00147	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling by GPCR—IL5—atopic dermatitis	0.000132	0.00146	CbGpPWpGaD
Hydrocodone—OPRM1—GPCR downstream signaling—CCR3—atopic dermatitis	0.00013	0.00144	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—KIF3A—atopic dermatitis	0.000127	0.00141	CbGpPWpGaD
Hydrocodone—OPRK1—GPCR downstream signaling—IL5—atopic dermatitis	0.000127	0.00141	CbGpPWpGaD
Hydrocodone—OPRM1—GPCR ligand binding—CCR5—atopic dermatitis	0.000126	0.0014	CbGpPWpGaD
Hydrocodone—OPRM1—G alpha (i) signalling events—CXCL8—atopic dermatitis	0.000125	0.0014	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—CCL17—atopic dermatitis	0.000125	0.00139	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling by GPCR—TAC1—atopic dermatitis	0.000124	0.00138	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling by GPCR—NPS—atopic dermatitis	0.000124	0.00138	CbGpPWpGaD
Hydrocodone—OPRD1—GPCR downstream signaling—CXCL10—atopic dermatitis	0.000124	0.00137	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling by GPCR—CXCR3—atopic dermatitis	0.000122	0.00135	CbGpPWpGaD
Hydrocodone—OPRK1—Class A/1 (Rhodopsin-like receptors)—CXCL8—atopic dermatitis	0.000118	0.00131	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—CCL27—atopic dermatitis	0.000118	0.00131	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling by GPCR—CCR3—atopic dermatitis	0.000118	0.00131	CbGpPWpGaD
Hydrocodone—OPRM1—GPCR downstream signaling—TAC1—atopic dermatitis	0.000116	0.00128	CbGpPWpGaD
Hydrocodone—OPRM1—GPCR downstream signaling—NPS—atopic dermatitis	0.000116	0.00128	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling by GPCR—IL5—atopic dermatitis	0.000115	0.00128	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—CCL11—atopic dermatitis	0.000115	0.00128	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—CMA1—atopic dermatitis	0.000115	0.00128	CbGpPWpGaD
Hydrocodone—OPRM1—GPCR downstream signaling—CXCR3—atopic dermatitis	0.000113	0.00126	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling by GPCR—CXCL10—atopic dermatitis	0.000112	0.00125	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—KIF3A—atopic dermatitis	0.000112	0.00124	CbGpPWpGaD
Hydrocodone—OPRK1—GPCR downstream signaling—CXCL10—atopic dermatitis	0.000108	0.0012	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—STAT6—atopic dermatitis	0.000108	0.0012	CbGpPWpGaD
Hydrocodone—OPRM1—GPCR downstream signaling—IL5—atopic dermatitis	0.000107	0.00119	CbGpPWpGaD
Hydrocodone—OPRD1—GPCR downstream signaling—CCL5—atopic dermatitis	0.000106	0.00118	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—CCL17—atopic dermatitis	0.000106	0.00118	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling by GPCR—TAC1—atopic dermatitis	0.000105	0.00117	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling by GPCR—NPS—atopic dermatitis	0.000105	0.00117	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling by GPCR—CXCR3—atopic dermatitis	0.000103	0.00114	CbGpPWpGaD
Hydrocodone—OPRD1—GPCR ligand binding—CXCL8—atopic dermatitis	0.000103	0.00114	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—CMA1—atopic dermatitis	0.000101	0.00112	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—CCL11—atopic dermatitis	0.000101	0.00112	CbGpPWpGaD
Hydrocodone—OPRM1—Class A/1 (Rhodopsin-like receptors)—CXCL8—atopic dermatitis	9.98e-05	0.00111	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling by GPCR—CXCL10—atopic dermatitis	9.84e-05	0.00109	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling by GPCR—IL5—atopic dermatitis	9.75e-05	0.00108	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling by GPCR—CCL5—atopic dermatitis	9.66e-05	0.00107	CbGpPWpGaD
Hydrocodone—OPRD1—GPCR downstream signaling—CCR5—atopic dermatitis	9.58e-05	0.00107	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—STAT6—atopic dermatitis	9.49e-05	0.00105	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—KIF3A—atopic dermatitis	9.43e-05	0.00105	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—CCR3—atopic dermatitis	9.38e-05	0.00104	CbGpPWpGaD
Hydrocodone—OPRK1—GPCR downstream signaling—CCL5—atopic dermatitis	9.33e-05	0.00104	CbGpPWpGaD
Hydrocodone—OPRM1—GPCR downstream signaling—CXCL10—atopic dermatitis	9.16e-05	0.00102	CbGpPWpGaD
Hydrocodone—OPRK1—GPCR ligand binding—CXCL8—atopic dermatitis	8.99e-05	0.000999	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling by GPCR—CCR5—atopic dermatitis	8.7e-05	0.000968	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—CCL11—atopic dermatitis	8.53e-05	0.000948	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—CMA1—atopic dermatitis	8.53e-05	0.000948	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling by GPCR—CCL5—atopic dermatitis	8.47e-05	0.000942	CbGpPWpGaD
Hydrocodone—OPRK1—GPCR downstream signaling—CCR5—atopic dermatitis	8.4e-05	0.000934	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—NPS—atopic dermatitis	8.36e-05	0.00093	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—TAC1—atopic dermatitis	8.36e-05	0.00093	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling by GPCR—CXCL10—atopic dermatitis	8.32e-05	0.000925	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—CCR3—atopic dermatitis	8.23e-05	0.000915	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—CXCR3—atopic dermatitis	8.2e-05	0.000912	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—STAT6—atopic dermatitis	8.02e-05	0.000892	CbGpPWpGaD
Hydrocodone—OPRM1—GPCR downstream signaling—CCL5—atopic dermatitis	7.88e-05	0.000876	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—IL5—atopic dermatitis	7.77e-05	0.000864	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling by GPCR—CCR5—atopic dermatitis	7.63e-05	0.000848	CbGpPWpGaD
Hydrocodone—OPRM1—GPCR ligand binding—CXCL8—atopic dermatitis	7.6e-05	0.000845	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—TAC1—atopic dermatitis	7.33e-05	0.000815	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—NPS—atopic dermatitis	7.33e-05	0.000815	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—CXCR3—atopic dermatitis	7.19e-05	0.000799	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling by GPCR—CCL5—atopic dermatitis	7.16e-05	0.000796	CbGpPWpGaD
Hydrocodone—OPRM1—GPCR downstream signaling—CCR5—atopic dermatitis	7.1e-05	0.00079	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—CCR3—atopic dermatitis	6.95e-05	0.000773	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—IL5—atopic dermatitis	6.82e-05	0.000758	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—CXCL10—atopic dermatitis	6.63e-05	0.000737	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling by GPCR—CCR5—atopic dermatitis	6.45e-05	0.000717	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—TAC1—atopic dermatitis	6.2e-05	0.000689	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—NPS—atopic dermatitis	6.2e-05	0.000689	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—CXCR3—atopic dermatitis	6.08e-05	0.000676	CbGpPWpGaD
Hydrocodone—CYP2D6—Metabolism—GLB1—atopic dermatitis	5.95e-05	0.000662	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—CXCL10—atopic dermatitis	5.81e-05	0.000646	CbGpPWpGaD
Hydrocodone—OPRD1—GPCR downstream signaling—CXCL8—atopic dermatitis	5.79e-05	0.000644	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—IL5—atopic dermatitis	5.76e-05	0.000641	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—CCL5—atopic dermatitis	5.71e-05	0.000634	CbGpPWpGaD
Hydrocodone—CYP2D6—Metabolism—ADSL—atopic dermatitis	5.7e-05	0.000634	CbGpPWpGaD
Hydrocodone—OPRD1—GPCR downstream signaling—IL2—atopic dermatitis	5.54e-05	0.000616	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—NGF—atopic dermatitis	5.28e-05	0.000588	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling by GPCR—CXCL8—atopic dermatitis	5.26e-05	0.000585	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—CCR5—atopic dermatitis	5.14e-05	0.000572	CbGpPWpGaD
Hydrocodone—OPRK1—GPCR downstream signaling—CXCL8—atopic dermatitis	5.08e-05	0.000565	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling by GPCR—IL2—atopic dermatitis	5.03e-05	0.000559	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—CCL5—atopic dermatitis	5e-05	0.000556	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—CXCL10—atopic dermatitis	4.91e-05	0.000546	CbGpPWpGaD
Hydrocodone—OPRK1—GPCR downstream signaling—IL2—atopic dermatitis	4.85e-05	0.00054	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—NGF—atopic dermatitis	4.63e-05	0.000515	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling by GPCR—CXCL8—atopic dermatitis	4.61e-05	0.000513	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—CCR5—atopic dermatitis	4.51e-05	0.000501	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling by GPCR—IL2—atopic dermatitis	4.41e-05	0.00049	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—NFKBIA—atopic dermatitis	4.36e-05	0.000485	CbGpPWpGaD
Hydrocodone—OPRM1—GPCR downstream signaling—CXCL8—atopic dermatitis	4.29e-05	0.000477	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—CCL5—atopic dermatitis	4.23e-05	0.00047	CbGpPWpGaD
Hydrocodone—OPRM1—GPCR downstream signaling—IL2—atopic dermatitis	4.1e-05	0.000456	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—NGF—atopic dermatitis	3.92e-05	0.000435	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling by GPCR—CXCL8—atopic dermatitis	3.9e-05	0.000433	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—GLB1—atopic dermatitis	3.89e-05	0.000433	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—NFKBIA—atopic dermatitis	3.82e-05	0.000425	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—CCR5—atopic dermatitis	3.81e-05	0.000424	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—ADSL—atopic dermatitis	3.73e-05	0.000415	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling by GPCR—IL2—atopic dermatitis	3.73e-05	0.000414	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—NFKBIA—atopic dermatitis	3.23e-05	0.000359	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—CXCL8—atopic dermatitis	3.11e-05	0.000346	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—IL2—atopic dermatitis	2.97e-05	0.00033	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling by GPCR—IL6—atopic dermatitis	2.96e-05	0.000329	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—MAPK8—atopic dermatitis	2.73e-05	0.000304	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—CXCL8—atopic dermatitis	2.73e-05	0.000303	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—IL2—atopic dermatitis	2.6e-05	0.00029	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling by GPCR—IL6—atopic dermatitis	2.59e-05	0.000288	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—MAPK8—atopic dermatitis	2.4e-05	0.000267	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—CXCL8—atopic dermatitis	2.3e-05	0.000256	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—IL2—atopic dermatitis	2.2e-05	0.000245	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling by GPCR—IL6—atopic dermatitis	2.19e-05	0.000244	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—MAPK8—atopic dermatitis	2.03e-05	0.000225	CbGpPWpGaD
Hydrocodone—CYP2D6—Metabolism—PPARA—atopic dermatitis	1.93e-05	0.000215	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—IL6—atopic dermatitis	1.75e-05	0.000194	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—IL6—atopic dermatitis	1.53e-05	0.00017	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—IL6—atopic dermatitis	1.29e-05	0.000144	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—PPARA—atopic dermatitis	1.26e-05	0.00014	CbGpPWpGaD
